Trial
NCT00866684
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Charite University, Berlin, Germany
Collaborators
—
Condition
Skin Cancer
Intervention
Sirolimus
Why stopped
Insufficient patient recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-14